mRNA‐based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Genetics

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cge.12802PMID 27174726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides

  2016cited by this paper
• Refining the continuum of CFTR‐associated disorders in the era of newborn screening

  2016cited by this paper
• Progress in therapies for cystic fibrosis.

  2016cited by this paper
• Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients

  2015cited by this paper
• Small-scale high-throughput sequencing–based identification of new therapeutic tools in cystic fibrosis

  2015cited by this paper
• Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene

  2013cited by this paper
• Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility

  2013cited by this paper
• A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients.

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

  2008cited by this paper
• Cystic fibrosis: terminology and diagnostic algorithms

  2005cited by this paper
• Cystic fibrosis.

  2005cited by this paper
• The role of common single‐nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR Alleles

  2004cited by this paper
• Cystic fibrosis

  2003cited by this paper
• CFTR genotypes in patients with normal or borderline sweat chloride levels

  2003cited by this paper
• Variant cystic fibrosis phenotypes in the absence of CFTR mutations.

  2002cited by this paper
• Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study

  2001cited by this paper
• The 3120+1GA Splicing Mutation in CFTR Is Common in Brazilian Cystic Fibrosis Patients

  2001cited by this paper
• Cystic fibrosis patients with the 3272‐26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane

  1999cited by this paper
• High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes

  1997cited by this paper
• First report of CFTR mutations in black cystic fibrosis patients of southern African origin.

  1996cited by this paper
• Analysis of the CFTR gene in the Spanish population: SSCP‐screening for 60 known mutations and identification of four new mutations (Q30X, A120T, 1812‐1 G→A, and 3667de14)

  1994cited by this paper

• Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids

  2025cites this paper
• VIsoQLR: an interactive tool for the detection, quantification and fine-tuning of isoforms in selected genes using long-read sequencing

  2023cites this paper
• Mutation-class dependent signatures outweigh disease-associated processes in cystic fibrosis cells

  2023cites this paper
• Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis.

  2022cites this paper
• Genetics of Cystic Fibrosis: Clinical Implications.

  2022cites this paper
• ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction.

  2022cites this paper
• A step forward for an intermediate cystic fibrosis population

  2022cites this paper
• Current and future diagnosis of cystic fibrosis: Performance and limitations.

  2020cites this paper
• Cystic Fibrosis Diagnosis in Newborns, Children, and Adults

  2019cites this paper
• R560S: A class II CFTR mutation that is not rescued by current modulators.

  2019influential citation
• Current and future molecular approaches in the diagnosis of cystic fibrosis

  2018cites this paper
• Cystic Fibrosis: Novel Molecular Imaging Tools

  2018cites this paper
• Using a systems approach to identify the mechanism of action of correctors

  2018cites this paper
• The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read‐through therapies in cystic fibrosis

  2018cites this paper
• Study and characterization of CFTR mutations in vitro and in native tissues from non CF patients with chronic airways diseases

  2017cites this paper
• New era of cystic fibrosis: Full mutational analysis and personalized therapy

  2017cites this paper
• Využití sekvenačních metod nové generace pro objasnění fenotypu podobného CF u pacientů s nejasnou molekulární podstatou onemocnění.

  2017cites this paper